Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1657
-0.0026(-0.23%)
GBP/USD
1.2550
+0.0017(+0.14%)
Bitcoin GBP
49,279.75
+2,094.51(+4.44%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Healthcare Triangle, Inc. (HCTI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.2501

+0.0201

(+1.61%)

As of 02:17PM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	5.72M
Enterprise value	8.80M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.16
Price/book (mrq)	10.63
Enterprise value/revenue	0.27
Enterprise value/EBITDA	-2.14

Trading information

Stock price history

Beta (5Y monthly)	0.99
52-week change ³	-49.38%
S&P500 52-week change ³	22.43%
52-week high ³	10.8900
52-week low ³	1.1700
50-day moving average ³	1.7272
200-day moving average ³	3.1600

Share statistics

Avg vol (3-month) ³	132.86k
Avg vol (10-day) ³	18k
Shares outstanding ⁵	4.65M
Implied shares outstanding ⁶	4.65M
Float ⁸	1.9M
% held by insiders ¹	58.02%
% held by institutions ¹	0.31%
Shares short (15 Apr 2024) ⁴	66.86k
Short ratio (15 Apr 2024) ⁴	0.47
Short % of float (15 Apr 2024) ⁴	3.36%
Short % of shares outstanding (15 Apr 2024) ⁴	1.44%
Shares short (prior month 15 Mar 2024) ⁴	95.18k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:10
Last split date ³	26 May 2023

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-37.16%
Operating margin (ttm)	-71.11%

Management effectiveness

Return on assets (ttm)	-46.04%
Return on equity (ttm)	-190.92%

Income statement

Revenue (ttm)	33.2M
Revenue per share (ttm)	7.85
Quarterly revenue growth (yoy)	-37.50%
Gross profit (ttm)	N/A
EBITDA	-4.12M
Net income avi to common (ttm)	-12.34M
Diluted EPS (ttm)	-2.9200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	1.23M
Total cash per share (mrq)	0.26
Total debt (mrq)	4.32M
Total debt/equity (mrq)	802.42%
Current ratio (mrq)	0.70
Book value per share (mrq)	0.12

Cash flow statement

Operating cash flow (ttm)	-1.61M
Levered free cash flow (ttm)	2.46M